Aspen Aerogels, Inc. (NYSE:ASPN) reported better-than-expected earnings for its fourth quarter on Thursday.
The company posted quarterly earnings of 14 cents per share which beat the analyst consensus estimate of 8 cents per share. The company reported quarterly sales of $123.09 million which beat the analyst consensus estimate of $120.80 million.
“Our financial results for 2024 underscore the scalability of our business model and leading market position,” commented Don Young, Aspen’s President and CEO. “In addition to exceeding our initial 2024 revenue and profitability expectations, we added multiple OEMs to our growing list of customers, including the recent award from Volvo Truck, and established external manufacturing capabilities to provide supply for our growing Energy Industrial business. We are taking a prudent approach to 2025 and are implementing several actions that increase our agility and capital efficiency.”
Aspen said it sees first-quarter revenue to range between $75 million and $95 million and net loss per share to range between $0.18 and breakeven.
Aspen Aerogels shares fell 0.6% to trade at $8.95 on Friday.
These analysts made changes to their price targets on Aspen Aerogels following earnings announcement.
Considering buying ASPN stock? Here’s what analysts think:
Read This Next:
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。